Surge Components (Surge Components) Cash And Cash Equivalents : $9.09 Mil (As of Feb. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Surge Components Cash And Cash Equivalents?

Surge Components's quarterly cash and cash equivalents increased from Aug. 2023 ($5.96 Mil) to Nov. 2023 ($7.64 Mil) and increased from Nov. 2023 ($7.64 Mil) to Feb. 2024 ($9.09 Mil).

Surge Components's annual cash and cash equivalents increased from Nov. 2021 ($6.51 Mil) to Nov. 2022 ($8.69 Mil) but then declined from Nov. 2022 ($8.69 Mil) to Nov. 2023 ($7.64 Mil).

Surge Components Cash And Cash Equivalents Historical Data

The historical data trend for Surge Components's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surge Components Cash And Cash Equivalents Chart

Surge Components Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Cash And Cash Equivalents

Get a 7-Day Free Trial

2.74

4.39

6.51

8.69

7.64

Surge Components Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Cash And Cash Equivalents	Get a 7-Day Free Trial															10.19	8.80	5.96	7.64	9.09

Surge Components Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Surge Components (OTCPK:SPRS) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Surge Components Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Surge Components's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Surge Components (Surge Components) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Surge Components Inc (OTCPK:SPRS) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

95 East Jefryn Boulevard, Deer Park, New York, NY, USA, 11729

Website

https://www.surgecomponents.com

Surge Components Inc is a supplier of electronic products and components. The company's products include capacitors, which are electrical energy storage devices, and discrete components, such as rectifiers, transistors, and diodes. Its marketed products are utilized in the electronic circuitry of products, comprising of automobiles, telecom, audio, cellular telephones, computers, consumer electronics, garage door openers, household appliances, power supplies and security equipment. In addition, the company's products are also sold to original equipment manufacturers and distributors.

Executives

Peter Levy	director	C/O ATLAS THERAPEUTICS CORPORATION, 4640 ADMIRALTY WAY, SUITE 500, MARINA DEL REY CA 90292
Michael D Tofias	10 percent owner	325 NORTH END AVENUE, APT. 25B, NEW YORK NY 10282
Steven J Lubman	director, officer: VP, Secretary, Director	1016 GRAND BLVD, DEER PARK NY 11729
Martin Novick	director
Alan Plafker	director	24 SYLVIA ROAD, PLAINVIEW NY 11803
Gary Mark Jacobs	director	15 HOOVER STREET, INWOOD NY 11096
Lawrence Chariton	director	30 ROCKAWAY PLACE, MASSAPEQUA NY 11758
Ira Levy	director, officer: Chief Executive Officer
David Siegel	director	95 EAST JEFRYN BOULEVARD, DEER PARK NY 11729